Skip to content

Polaryx Therapeutics, Inc. PLYX Preferred Stock Par Value Per Share

Preferred Stock Par Value Per Share at other companies

Jefferies Financial Group logo
Jefferies Financial GroupJEF
$1.000.0%
Henry Schein logo
Henry ScheinHSIC
$0.010.0%
Morgan Stanley logo
Morgan StanleyMS
$0.010.0%
Our Bond, Inc.
 logo
Our Bond, Inc. OBAI
$0.000.0%
Otis Worldwide logo
Otis WorldwideOTIS
$0.010.0%
Manhattan Bridge Capital logo
Manhattan Bridge CapitalLOAN
$0.010.0%

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$115.64M

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's preferred stock par value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's preferred stock par value per share?
Polaryx Therapeutics, Inc. (PLYX) reported preferred stock par value per share of $0.00 in Q4 2025.
What does preferred stock par value per share mean?
The par value per share of preferred stock is a nominal value assigned to preferred shares for accounting and legal purposes. It does not reflect the market value or the liquidation preference of the stock. It is primarily a regulatory and historical accounting figure.